相关实验视频
Updated: Jun 12, 2025

Nerve Excitability Assessment in Chemotherapy-induced Neurotoxicity
Published on: April 26, 2012
[N-Check:神经检查记录化学疗法诱导的周围神经病变 (CIPN) 在无法治愈的癌症]
Annabell Syben1, Sascha Weber1,2, Iris Appelmann1
1Klinik für Palliativmedizin, Uniklinik der RWTH, Medizinische Fakultät, RWTH Aachen University, Pauwelsstraße 30, 52074, Aachen, Deutschland.
定量感官测试 (QST) 在息性癌症患者中有效识别了化疗诱导的多神经病变 (CIPN). 这项试点研究证明了QST.
科学领域:
- 在瘤学瘤学.
- 神经学 神经学
- 临床药理学 临床药理学
背景情况:
- 化疗诱导的多神经病变 (CIPN) 呈现出各种症状,影响患者的生活质量.
- CIPN是细胞静止药物的常见副作用,特别是在无法治愈的癌症患者中.
- 定量感官测试 (QST) 是评估感官感知和疼痛值的标准化方法.
研究的目的:
- 在接受神经毒性化疗的息性癌症患者中使用QST调查CIPN.
- 通过使用FACT-G问卷来评估CIPN对健康相关生活质量 (HRQoL) 的影响.
- 评估在这个患者群体中实施QST的可行性.
主要方法:
- 一项试点研究 (N-Check项目) 涉及化疗前后的QST.
- QST测量了热和机械感知以及疼痛值.
- 癌症治疗的功能评估一般 (FACT-G) 评估HRQoL.
主要成果:
- 患者在化疗后表现出显著的热量过敏症,表明小神经纤维受损.
- 观察到与健康有关的生活质量下降.
- QST被证明是可行的评估CIPN在息性癌症患者.
结论:
- 在息性癌症护理中,QST是检测化疗诱导的神经损伤的可行工具.
- 神经毒性化疗对感官功能和生活质量产生负面影响.
- 这项试点研究支持QST在CIPN监测中的常规使用.
更多相关视频
09:39Establishing a Mouse Model of a Pure Small Fiber Neuropathy with the Ultrapotent Agonist of Transient Receptor Potential Vanilloid Type 1
Published on: February 13, 2018
05:56Acupoint Application Combined with Acupressure as an Adjunctive Therapy for Chemotherapy-Induced Nausea and Vomiting
Published on: June 21, 2024
相关概念视频
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
Nursing Ethical Principles II
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's...
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
Two synthetic agonists of THC,...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...